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INTRODUCTION
The association of hyperlipidemia and oxidation with cardio-
vascular disease (CVD) has been well established. Increased lipid 
or oxidant level in blood might be an important risk factor for the 
development of CVD. Patients with hypercholesterolemia, hyper-
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ABSTRACT
Hyperlipidemia and oxidation play major roles upon cardiovascular diseases (CVDs). C-phycocyanin (CPC), the major component 
in blue-green algae, possesses antiinflammatory and radical scavenging properties. Herein we aimed to investigate the effect of CPC 
upon lipid metabolism and its antioxidant effects. Golden Syrian hamsters were randomly assigned to five groups: (1) control; (2) 0.2% 
cholesterol; (3) 0.2% cholesterol＋1% lopid; (4) 0.2% cholesterol＋0.25% CPC; and (5) 0.2% cholesterol＋1.25% CPC. All animals 
were sacrificed after 8-week feeding. Serum cholesterol, triglyceride (TG), low-density lipoprotein (LDL), glutamate-oxaloacetate 
transaminase (GOT), and glutamate-pyruvate transaminase (GPT) were examined. The diene conjugation in the Cu2+-mediated oxidation 
of LDL was measured. The protein levels of several antioxidative enzymes including catalase (CAT), superoxide dismutases (SOD), and 
glutathione peroxidase (GPx) of liver were assayed. HepG2 cells were cultured in medium containing various concentrations of CPC 
(0, 1, 15, and 30 μM). The mRNA concentrations of LDL receptor, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase, 
SOD-1 and GPx of HepG2 cells in each group were analyzed. CPC was effective in lowering serum cholesterol, total cholesterol (TC), 
TG, LDL, GOT, and GPT. CPC was found to decrease the malondialdehyde (MDA) equivalents and delay the diene conjugation in the 
Cu2+-mediated oxidation of LDL. CPC increase the enzyme expressions of CAT, SOD, and GPx. CPC concentrations were positively 
correlated with the mRNA level of LDL receptor while the mRNA levels of HMG CoA reductase, SOD-1, and GPx in HepG2 cells were 
not affected. The lipid-lowering and antioxidation effects of CPC suggest its roles in prevention of CVD and atherosclerotic formation.
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triglycemia, impaired antioxidation have a high incidence of CVD 
as well as increased morbidity and mortality.[1] Hyperlipidemia or 
compromised oxidation might interrupt the endothelial dysfunc-
tion.[2] Recent studies also suggested the immunity impairment as 
an early mechanism for ischemia-reperfusion affair for CVD.[3] 
Reactive oxygen species (ROS) play important roles in the 
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development of CVD.[4] Abnormal ROS production might interfere 
with vascular function. Free radicals have beneficial or detrimental 
effects upon vascular wall, which depend on their nature and con-
centration.[5] ROS such as superoxide anion, hydroxyl radical, and 
hydrogen peroxide are crucial in inflammatory responses, where 
they participate in physiological processes such as the arachi-
donic acid cascade and phagocytosis.[6] The equilibrium between 
the amounts of ROS produced and scavenged is related with the 
gamete cell stability and damage.[5] Numerous antioxidants are re-
lated with the ROS detoxification, including superoxide dismutase 
(SOD), catalase, and glutathione peroxidase (GPx). SOD and GPx 
could dispose hydrogen peroxide and other ROS.[7] 
C-phycocyanin (CPC), a blue colored, fluorescent protein puri-
fied from blue-green algae, is often used as a dietary nutritional 
supplement. CPC has been associated with antiinflammatory and 
radical scavenging properties.[8] CPC has also been demonstrated 
to improve serum lipids and may reduce the risk of CVD.[9] Nu-
merous clinical effects of CPC have been demonstrated, includ-
ing antiinflammatory activity,[10] antiapoptosis,[11] antioxidant,[12] 
antiradiation,[13] etc. However, little is known about the molecular 
mechanisms of CPC in these aspects. Furthermore, its roles upon 
cardiovascular system, lipid metabolism, and ROS remain to be 
explored.
The clinical application of CPC and its mechanism through 
which CPC improves CVD have yet to be fully elucidated. In this 
survey, we designed to determine the effects of CPC upon the 
cholesterol, lipid, and ROS metabolism. We aimed to investigate 
the effects of CPC on the lipid and ROS metabolism of hamster 
fed with a high cholesterol diet. To the best of our knowledge, 
this survey is the first report in these related aspects.
MATERIALS AND METHODS
Animal preparation
A total of 56 male Golden Syrian hamsters (7 weeks old) were 
randomly assigned to five groups including (1) control; (2) 0.2% 
cholesterol; (3) 0.2% cholesterol＋1% lopid; (4) 0.2% choles-
terol＋0.25% CPC; and (5) 0.2% cholesterol＋1.25% CPC. The 
ambient temperature was maintained between 22 and 24°C and 
the animals were kept on an artificial 12-h light–dark cycle. All 
protocols were approved by the Institutional Animal Care and Use 
Committee of China Medical University, Taichung, Taiwan. After 
8-week feeding, all hamsters were sacrificed.
Measurement of plasma lipid level
The blood samples were collected in EDTA-coated glass 
tubes and centrifuged at 1000×g for 15 min at 4°C. The plasma 
was then separated and the total cholesterol (TC), triglyceride 
(TG), low-density lipoprotein cholesterol (LDL-C), and high-
density lipoprotein cholesterol (HDL-C) concentrations were 
assayed by commercial kits (Randox, San Diego, CA, USA). 
The protocols are described briefly as follows. TG detection: 
Serum was processed by enzymatic GPO-PAP method by us-
ing lipoproteinlipase, glycerol-kinase, glycerol-3-phosphate 
oxidase, and peroxidase to form a final product 4-(o-benzo-
quinone-monoimido) phenazone with pink red color. The 
concentration of TG can then be determined at 500 nm. TC 
detection: Serum was processed by enzymatic CHOD-PAP 
method. Olyethylene-glycol-(p-(1,1,3,3,-tetramethy-butyl)-
phenyl)-ether and polyethyleneglycol monoalkyl ether were 
used to release cholesterol from lipoprotein release. Cholesterol 
was then hydrolyzed by cholesterol esterase followed by reac-




, which was then 
catalyzed by peroxidase and reacted with 4-aminoantipyrin and 
phenol to yield pale red color Quinoneimine. The concentration 
of TC can then be determined at 500 nm. HDL-C detection: 
The VLDL and LDL in the plasma were precipitated by phos-
photungstic acid and Mg2+ followed by 1000×g centrifugation 
for 15 min. The concentration of HDL in the supernatant was 
determined by the enzymatic CHOD-PAP method as described 
in the TC assay. LDL detection: The LDL in the plasma was 
precipitated by polyvinylsulfate followed by 1000×g centrifu-
gation for 15 min. The cholesterol level other than LDL in the 
supernatant was determined by enzymatic DHOD-PAP method. 
The LDL concentration can then be determined by subtracting 
the supernatant cholesterol from TC level.
Copper-induced oxidation of LDL
LDL was then isolated by single-step nonequilibrium density 
gradient ultracentrifugation (Beckman TL-100, Beckman, Palo 
Alto, CA, USA) using a TLV-100 vertical rotor at 100,000 rpm 
for 30 min at 10°C. The isolated LDL fraction was desalted by 
passing it through a gel filtration column (Econo-Pac 10 DG, 
Bio Rad Laboratories, CA, USA). LDL was collected in 0.7 ml 
of phosphate buffered saline (PBS). The protein concentration 
of the eluate was measured using bovine serum albumin as 
standard. For the oxidation experiment, the LDL preparations 
were diluted with PBS to contain 0.05 g/l protein (≈0.1 μmol/l 
LDL). Oxidation was started by adding 10 μl of freshly prepared 
0.167 mmol/l CuSO
4
 to 1.0 ml of LDL solution in a 1 cm quartz 
cuvette. Oxidation was determined as the production of hydro-
peroxides with conjugated double bonds (conjugated dienes) by 
continuously (at 1 min intervals for 8 h) monitoring the change 
in absorbance at 234 nm at 37°C. Several indices were obtained 
from the absorbance versus time curves: the initial absorbance 
of the sample was recorded to assess the baseline level of con-
jugated dienes (BDC, μmol/l) formed in the circulation prior to 
the isolation of LDL. The lag time (min) was determined from 
the intercept of lines drawn through the linear portions of the 
lag phase and the propagation phase.
TBARS levels
Malondialdehyde in plasma was determined by a modifica-
tion of the method of Huang et al.[14] Briefly, the assay mixture 
consisted of 25 µl of the plasma, 2.5 µl of 60 mM CuSO
4
, and 
22.5 µl of H
2
O and was incubated for 4 hours at 37°C. The mix-
ture was then mixed with 0.35 ml of 20% trichloroacetic acid 
(TCA) and 0.35 ml of 0.67% thiobarbituric acid (TBA) and was 
heated for 30 min at 70°C. After centrifugation at 10,000 rpm 
for 2.5 min, the supernatant was assayed spectrophotometrically 
at 540 nm. Since other aldehydic compounds in the sample may 
be measured, the plasma malondialdehyde (MDA) content was 
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expressed as thiobarbituric acid-reactive substances (TBARS, 
MDA equivalent) in nM.
Measurement of enzymatic activities of SOD, CAT, and 
GSH-Px in liver
Liver proteins for enzymatic activity assay were extracted 
from tissue treated with or without CPC according to the previ-
ously published protocols.[15] SOD activity was assayed by a 
commercial kit Ransod (Randox, San Diego, CA, USA). Enzyme 
activity of SOD was defined as one U to inhibit the reducing rate 
of 2-(-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride 
by 50%. The SOD activity is denoted as U/mg protein. GSH-Px 
activity was assayed by a commercial kit Ransel (Randox, San 
Diego, CA, USA). Enzyme activity of GSH-Px was defined as one 
U to oxidize 1 μmol nicotinamide adenine dinucleotide phosphate 
(NADPH) in 1 min. The GSH-Px activity is denoted as mU/mg 
protein. The assay of CAT was based on the protocol published by 
Aebi.[16] The CAT activity is denoted as U/mg protein.
Cell culture
Human hepatocellular carcinoma cell line (HepG2) were 
purchased from Food Industry Research and Development 
Institute (Hsinchu, Taiwan) and cultured in Dulbecco`s modi-
fied eagle medium (DMEM) for further study. DMEM medium 
was composed with 10,000 units/ml penicillin/streptomycin, 
NaHCO
3
, and 10 % fetal bovine serum (FBS). The culture of 
HepG2 cells were performed as previously described.[17] The 
addition of different concentration of CPC (0.5% FBS, 1, 15, 30 
μM) in each culture cells was made to observed the influences of 
CPC upon HepG2 cell growth. After 2 week culture, the HepG2 
cells were harvested.
Real-Time PCR analysis
Total RNAs of HepG2 cells were extracted with Trizol reagent 
(Invitrogen). One microgram of each total RNA was reverse tran-
scribed into cDNA using the RNA PCR kit (Invitrogen) using oligo 
(dT) primer. The reaction was carried out at 50°C for 60 min. The 
reverse transcriptase was inactivated with incubation at 98°C for 
5 min and kept at 4°C. 
The following real-time polymerase chain reaction (PCR) was 
performed according to the manufacture protocol (Boehringer 
Mannheim). The reverse transcription reaction products were 
measured by PCR analysis, using mRNA encoding rat b-actin 
as an internal standard. All PCR reactions were performed as 
follows: 1 µl of cDNA was used for amplification with 1 U Taq 
DNA polymerase (Qiagen, Hilden, Germany), 5 µl PCR buffer, 
5 µl 10 mM dNTPs (each), and 1 pmol of each specific upstream 
and downstream primer. The individual primer sequences and 
PCR conditions were designed as shown in [Table 3 (16)]. The 
real-time PCR for glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), SOD1, GPx, low-density lipoprotein receptor (LDLR), 
and HMG-CoA reductase (or 3-hydroxy-3-methyl-glutaryl-CoA 
reductase or HMGCR) was performed as previously described.[17] 
The primer pairs (forward and reverse primers) used in real-
time PCR to determine the pharmacological effects of CPC on 
3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase, 
SOD-1, and GPx were shown [Table 1].
Statistical analysis
All data in each group are presented as mean ± standard 
deviation (SD). The lipid levels and mRNA levels for GAPDH, 
SOD-1, GPx, LDLR, and HMGR in each group were determined 
and compared. The SAS system (version 8.1, SAS Institute Inc., 
Cary, North Carolina, USA) with unpaired Student’s t-test was 
utilized for statistical analyses. A P-value <0.05 was considered 
statistically significant.
RESULTS
CPC effectively inhibits lipid profiles
CPC was effective in lowering serum TC, TG, and LDL [Table 2] 
Table 1. The primer pairs used in real-time PCR to determine the pharmacological effects of CPC
Forward primer Reverse primer Product Tm
GAPDH TGCCAAGTATGATGACATCAAGAAG AGCCCAGGATGCCCTTTAGT 84°C
SOD-1 AGCGGATGAAGAGAGGCATGT CACACGATCTTCAATGGACAAT 88°C
GPx TGCGAGGTGAATGGTGAGAA GGTGCTGGCAAGGCATTC 90°C
LDLR TGGCTGCGTTAATGTGACACTC AGCCGATCTTAAGGTCATTGC 86°C
HMGR CTGTCATTCCAGCCAAGGTTG GTCCACAGGCAATGTAGATGG 86°C
Table 2. Serum concentrations of total cholesterol (TC), triacylglycerol (TG), low density lipoprotein (LDL), GOT, GPT levels affected by 8 weeks 
of CPC treatment
Normal group Cholesterol group 1% Lopid group 0.25% CPC group 1.25% CPC group
TC, mg/dl 141±4.65*** 308±4.86 253±13.38** 225±6.09*** 141±11.93***
TG, mg/dl 66±5.04*** 164±18.24 126±10.82 92±12.29** 87±5.60**
LDL, mg/dl 34±1.15*** 157±5.75 113±10.33 82±4.66*** 53±9.57***
GOT, U/L 46±2.59*** 122±12.72 81±10.92*** 54±3.70*** 49±3.19***
GPT, U/L 74±2.26*** 258±6.83 122±7.76*** 165±4.56*** 85±1.95***
**significantly different (P<0.01) when compared with cholesterol group by Student’s t-test. ***significantly different (P<0.001) when compared with 
cholesterol group.
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in hamsters. In comparing the cholesterol group, we observed 
the facts that CPC at both concentrations (0.25% and 1.25%) 
effectively inhibited TC, TG, and LDL serum levels [Table 2]. 
Assessment of liver functions in GOT and GPT serum activities
CPC significantly reduces glutamate-oxaloacetate transami-
nase (GOT) and glutamate-pyruvate transaminase (GPT) [Table 2] 
in hamsters. In comparing the cholesterol group, we observed the 
facts that CPC at both concentrations (0.25% and 1.25%) effectively 
reduced the serum concentrations of GOT and GPT [Table 2].
CPC delays the copper-induced oxidation of LDL
Our results demonstrated that CPC delayed the diene conju-
gation in the Cu2+-mediated oxidation as lag time was found to 
be increased [Table 3]. The lag time for cholesterol, 0.25%, and 
1.25% CPC groups were 213.3, 251.7, and 275 min, respectively.
CPC reduces TBARS levels in hamster plasma
The MDA content, a measure of lipid peroxidation, was as-
sayed in the form of TBARS as previously described.[14] Choles-
terol ingestion was associated with increase of MDA equivalent 
formation. CPC at 0.25% and 1.25% both significantly reduced 
the formation of TBARS (MDA equivalents) when compared with 
the cholesterol group [Figure 1]. 
Measurement of antioxidant enzymes activities of SOD, 
GPx, and CAT in liver
The activities of SOD, GPx, and CAT of animals in hyper-
cholesterolemia status decreased [Figures 2-4]. Our result dem-
onstrated that CPC at 1.25% effectively increased the activities of 
SOD, GPx, and catalase, respectively [Figures 2-4]. 
CPC effects on LDL receptor, HMG CoA reductase, SOD-1, 
and GPx mRNA levels 
The concentrations of CPC addition were positively cor-
related with the mRNA levels of LDL receptor in HepG2cells 
[Figure 5]. CPC at 30 μM appeared to increase levels of mRNA 
of LDL receptor. The lower concentrations of CPC (1 and 15 
Figure 1. The inhibitory effects of CPC on MDA equivalent formation in 
hamsters fed with various diets. ***significantly different (P<0.001) when 
compared with cholesterol group
Figure 3. The activities of GSH-Px in hamsters were increased by 
CPC treatment. *significantly different (P<0.05) when compared with 
cholesterol group
Figure 4. The activities of catalase in hamsters were increased by CPC 
treatment. ＊＊significantly different (P<0.01) when compared with 
cholesterol group
Figure 2. The effects of CPC on SOD enzyme activity of hamsters fed 
with various diets. ＊significantly different (P<0.05) when compared with 
cholesterol group by Student’s t-test. ＊＊significantly different (P<0.01) 
when compared with cholesterol group
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μM) were nonsignificantly influencing upon LDL receptor. In 
contrast, the concentrations of CPC addition were not associated 
with the mRNA levels of HMG CoA reductase, SOD-1, and GPx 
in Hep G2 cells [Figures 6-8]. The concentrations of HMG CoA 
reductase, SOD-1, and GPx in each group were nonsignificantly 
different [Figures 6-8].
DISCUSSION
CPC is one of the major biliproteins isolated from microalgae 
Spirulina. CPC has been found to have an antiinflammatory activity 
and exert beneficial effect in various diseases.[18] The inhibitory ac-
tivity of CPC on nitric oxide (NO), inducible nitric oxide synthase 
Figure 5. Effects of CPC on mRNA levels of LDL receptor in HepG2 
cell. ＊significantly different (P<0.05) when compared with 0.5% FBS 
control group
Figure 7. Effects of CPC on mRNA levels of SOD-1 reductase in HepG2 
cell
Figure 8. Effects of CPC on mRNA levels of GPx in HepG2 cell
Figure 6. Effects of CPC on mRNA levels of HMG CoA reductase in 
HepG2 cell
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(iNOS), or other lipopolysaccharide (LPS) is probably associated 
with suppressing the antiinflammatory activity.[10] CPC also play 
an antioxidant protector against cell lysis by peroxyl radicals.[19] 
The antiinflammatory effects of CPC might be associated with 
its inhibition of PGE
2
 and phospholipase A2 (PLA2) activities.[19] 
CPC also play a major role upon the protection against oxidative 
damage to DNA.[20]
Atherosclerosis is the main cause of arterial lesions and leads to 
arterial restenosis.[21] The regulation of vascular disorder involved 
may be complex and multifactor. Hyperlipidemia is associated with 
the mechanisms contributing to atherosclerosis atherosclerotic 
disease as well as the development of CVD. High blood lipid and 
oxidation of LDL have been known to play important roles in ath-
erosclerosis.[22] Therefore, lowering blood lipid or prolonging the 
lag phase of LDL oxidation has potential therapeutic applications 
to prevent atherogenesis. In this study, Lopid has been chosen as 
our positive control group due to the fact that Lopid can lower 
TG levels.[23] Lopid has also been described to decrease the risk 
of coronary heart disease by increasing HDL-C and decreasing 
LDL-C.[24] Our data clearly presents that CPC delays the diene 
conjugation in the Cu2+-mediated oxidation as lag time was in-
creased [Table 3].
Free radicals have beneficial or detrimental effects upon vas-
cular functions, which depend on their nature and concentration. 
The generations of ROS, such as superoxide anion, hydrogen 
peroxide, and the hydroxyl radical can result in the damage to 
cell membranes. Lipid peroxidation triggers the loss of membrane 
integrity, causing increased cell permeability, enzyme inactivation, 
structural damage to DNA, and cell death.[25] Oxidative stress has 
been implicated in the development of vascular disorder.
Higher SOD might scavenge the generation of ROS as well 
as lower the risk of CVD.[4] A balance is maintained between the 
amount of ROS and that scavenged by antioxidant. Cellular dam-
age arises when this equilibrium is disturbed, especially when the 
cellular scavenging systems cannot eliminate the increased ROS. 
Lipid peroxidation could damage the cell plasma membrane, which 
leads to loss of cytosolic components and cell death.
SOD is related with the scavenging of serum ROS. MDA, an 
end product of lipid peroxidation, represented the level of lipid 
peroxidation. GPx, a ROS scavenger, plays a role in protecting 
sperm membranes from the deleterious effects of lipid peroxida-
tion.[26] GPx is related with the balance between the GSSG (reduced 
form of glutathione) and GSH (oxidized form of glutathione).[27] 
Glutathione acts as a free radical scavenger and improves the 
semen quality. Glutathione could inhibit the lipid peroxidation 
of the cell membrane.[27] Reduced glutathione could protect sper-
matozoa from oxidative stress.[28] Through the interaction with 
GPx, reduced glutathione can neutralize hydroxyl radicals and 
detoxify the peroxides.[27] 
In this study, we observed that the CPC could effectively lower 
the serum levels of TC, TG, LDL, GOT, and GPT [Table 2]. We 
also observed its dose-dependent effect upon the elimination of 
TC, LDL, and GPT [Table 2]. Cholesterol/lipid might increase the 
level of ROS, whereas the CPC intake might compensate the cho-
lesterol/lipid compromise, which might increase the expressions 
of SOD, GPx, and catalase and decrease the expression of MDA. 
Also, CPC delayed the diene conjugation in the Cu2+-mediated 
oxidation as lag time was increased [Table 3]. On the basis of 
the abovementioned data, we did not find differences between 
0.25% CPC and 1.25% CPC groups [Tables 2 and 3]. Therefore, 
in the following studies we only chose 1.25% CPC for our studies. 
These findings suggest the clinical values of CPC upon the CVD 
individuals. We also observed that the concentrations of CPC ad-
dition were positively correlated with the mRNA concentration 
of LDL receptor in HepG2 cells [Figure 5]. In contrast, the CPC 
concentrations seem not to be associated with the mRNA concen-
tration of other markers, such as HMG CoA reductase [Figure 6], 
SOD-1 [Figure 7], and GPx [Figure 8]. Although their correlation 
was nonstatistically different, their correlation might exist after 
larger series included.
In conclusion, CPC are useful in the lipid-lowering and 
antioxidation, which suggest their roles in prevention of athero-
sclerotic formation and CVD susceptibilities. This could provide 
the database about the clinical roles of CPC upon lipid, ROS 
metabolism, as well as atherosclerosis or CVD pathogeneses. Our 
finding suggested that CPC might improve lipid profiles associ-
ated with CVD and the improving the compromised antioxidation 
condition. However, the real roles of its metabolic products and 
other herb medicines upon lipid and oxidant metabolism as well as 
the development of atherosclerosis or CVD merit further surveys. 
Furthermore, the dysfunctions of lipid or ROS are not the single 
determiner for the CVD or atherosclerosis. Other clinical values 
or roles of CPC upon CVD need further surveys. Larger scale or 
multiple factor surveys about CPC is required to clarify its fun-
damental roles upon CVD. Though, its molecular mechanisms 
underlying the cholesterol-lowering effect of CPC were not known, 
however, it is likely that CPC might regulate the turnover rate of 
LDL as shown by upregulation of LDLR. Also, antioxidation ef-
fects of CPC might contribute to less development of lipid profiles.
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